Editorial: Does metabolic dysfunction-associated steatotic liver disease with advanced fibrosis also equate to risk of advanced coronary artery disease? Authors' reply
| dc.contributor.author | Zhou, Xiao-Dong | |
| dc.contributor.author | Yılmaz, Yusuf | |
| dc.contributor.author | Zheng, Ming-Hua | |
| dc.date.accessioned | 2025-09-11T11:43:20Z | |
| dc.date.issued | 2025 | |
| dc.department | RTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | |
| dc.description.abstract | ...... | |
| dc.identifier.citation | Zhou, X. D., Yilmaz, Y., & Zheng, M. H. (2025). Editorial: Does Metabolic Dysfunction-Associated Steatotic Liver Disease With Advanced Fibrosis Also Equate to Risk of Advanced Coronary Artery Disease? Authors' Reply. Alimentary pharmacology & therapeutics, 10.1111/apt.70337. Advance online publication. https://doi.org/10.1111/apt.70337 | |
| dc.identifier.doi | 10.1111/apt.70337 | |
| dc.identifier.issn | 0269-2813 | |
| dc.identifier.pmid | 40808271 | |
| dc.identifier.scopus | 2-s2.0-105013041430 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.uri | https://doi.org/10.1111/apt.70337 | |
| dc.identifier.uri | https://hdl.handle.net/11436/11056 | |
| dc.identifier.wos | WOS:001550979100001 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.indekslendigikaynak | Web of Science | |
| dc.institutionauthor | Yılmaz, Yusuf | |
| dc.institutionauthorid | 0000-0003-4518-5283 | |
| dc.language.iso | en | |
| dc.publisher | John Wiley and Sons Inc | |
| dc.relation.ispartof | Alimentary Pharmacology and Therapeutics | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.title | Editorial: Does metabolic dysfunction-associated steatotic liver disease with advanced fibrosis also equate to risk of advanced coronary artery disease? Authors' reply | |
| dc.type | Editorial |
